| 000 | 01887 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515082553.0 | ||
| 264 | 0 | _c20080131 | |
| 008 | 200801s 0 0 eng d | ||
| 022 | _a1592-8721 | ||
| 024 | 7 |
_a10.3324/haematol.10680 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWeingrill, Eva | |
| 245 | 0 | 0 |
_aRoscovitine in B-chronic lymphocytic leukemia cells: high apoptosis-inducing efficacy and synergism with alemtuzumab independent of the patients' pretreatment status. _h[electronic resource] |
| 260 |
_bHaematologica _cSep 2007 |
||
| 300 |
_a1286-8 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlemtuzumab |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aAntibodies, Monoclonal, Humanized |
| 650 | 0 | 4 |
_aAntibodies, Neoplasm _xadministration & dosage |
| 650 | 0 | 4 |
_aAntigens, CD _xmetabolism |
| 650 | 0 | 4 |
_aAntigens, Neoplasm _xmetabolism |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 | _aCD52 Antigen |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMitoxantrone _xadministration & dosage |
| 650 | 0 | 4 |
_aPurines _xadministration & dosage |
| 650 | 0 | 4 | _aRoscovitine |
| 650 | 0 | 4 | _aSalvage Therapy |
| 700 | 1 | _aWölfler, Albert | |
| 700 | 1 | _aStrunk, Dirk | |
| 700 | 1 | _aLinkesch, Werner | |
| 700 | 1 | _aSill, Heinz | |
| 700 | 1 | _aLiebmann, Peter M | |
| 773 | 0 |
_tHaematologica _gvol. 92 _gno. 9 _gp. 1286-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3324/haematol.10680 _zAvailable from publisher's website |
| 999 |
_c17297177 _d17297177 |
||